US regulatory officials say they have identified not one but two supposed generic copies of the attention deficit hyperactive disorder (ADHD) treatment drug Concerta that have failed to demonstrate ...

After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

An internal US Food and Drug Administration (FDA) re-examination of previously submitted data has raised concerns that two generic medications used to treat attention ...

The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

A generic attention deficit hyperactive disorder (ADHD) drug manufactured by Mallinckrodt has been found by the US Food and Drug Administration (FDA) to not be sufficiently equivalent to its reference ...

“I’ve got X amount of (chemicals) to make Adderall with and lo and behold, by October I’m nearly out because more people are using the drugs than we anticipated,” Burke explained. Another complicating ...

Add Yahoo as a preferred source to see more of our stories on Google. More than a year after the Food and Drug Administration announced a nationwide shortage of Adderall, doctors and patients say they ...

Add Yahoo as a preferred source to see more of our stories on Google. Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug ...